<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Osteopontin (OPN), a phosphorylated <z:chebi fb="2" ids="17089">glycoprotein</z:chebi>, is involved in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Previously, we have reported that high OPN <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression level possessed clinicopathological or prognostic significance in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study is to investigate whether OPN can serve as a novel molecular target for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> therapy </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIAL AND METHODS: Western Blot assay was performed to detect the expression of OPN protein in 18 CRC and corresponding nontumor colon tissue samples </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="40" ids="33697">RNA</z:chebi> interference (RNAi) was employed to knockdown endogenous OPN expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell line (LoVo) </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="53233">MTT</z:chebi>, colony formation, and tumorigenicity assays were performed to analyze the effect of OPN downregulation on the in vitro and in vivo proliferation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>Wound healing and Matrigel invasion assays were performed to analyze the effect of OPN downregulation on migration and invasion of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="7" pm="."><plain>A clonogenic cell survival assay after radiation was performed to analyze the effect of OPN downregulation on the radiosensitivity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: The relative level of OPN protein expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues was significantly higher than that in corresponding nontumor colon tissues (P &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>We found that RNAi-mediated OPN downregulation could inhibit not only in vitro proliferation but also in vivo tumorigenicity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, OPN downregulation could suppress in vitro invasion capacity and enhance in vitro radiosensitivity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells, which might be associated with decreased levels of MMP-2 and -9 expression </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: RNAi-targeting OPN could inhibit proliferation, invasion and enhance radiosensitivity of human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="12" pm="."><plain>Therefore, OPN could serve as a novel molecular target for gene therapy of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>